Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Cao Y, Tong Q (2024 Hunting for heroes: Brain neurons mediating GLP-1R agonists in obesity treatment
10.1016/j.lfs.2019.116940 121 WangP.PeskoeS.ByrdR.SmithP.BreslinR.ChowS
Clinical trial data from withdrawal studies (such as SURMOUNT-4) demonstrate that patients regain weight after discontinuing GLP-1 receptor agonists and related medications
Emerging evidence also suggests that GLP-1 signaling may enhance the communication between enteric neurons and smooth muscle cells in the intestines, promoting more coordinated and efficient digestion
LIR is suitable to be administered once a day, with a t max of 9~13 hours and t 1/2 of 13 hours ( Compared with the treatment of short-acting GLP-1R agonists, LIR has a greater improvement in lowering glycated hemoglobin and fasting blood glucose
US$ 22.42
US$ 23.26
US$ 27.24
US$ 28.30
:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)
